Fuel Performance Solutions (IFUE) 10-K 31 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 31, 2015	Jun. 30, 2014
Document And Entity Information
Entity Registrant Name	FUEL PERFORMANCE SOLUTIONS, INC.
Entity Central Index Key	1078723
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$24,295,530
Entity Common Stock, Shares Outstanding		203,758,698
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$530,201	$216,913
Accounts receivable	338,572	10,781
Inventory	80,247	33,784
Deferred financing cost	127,555
Prepaid expenses and other assets	38,937	28,284
Total current assets	1,115,512	289,762
Goodwill	2,211,805	2,211,805
Total assets	3,327,317	2,501,567
Current liabilities
Accounts payable	507,044	350,984
Accrued compensation	787,026	742,465
Note payable to related parties		550,000
Deferred revenue		2,998,242
Derivative liability	457,380
Other accrued expenses	190,000	190,000
Total current liabilities	1,941,450	4,831,691
Convertible note payable, net of discount of $550,975 and $0, respectively	541,525
Convertible note payable - related party, net of discount of $28,999 and $0, respectively	28,501
Accrued interest	39,917
Accrued interest - related party	2,101
Deferred rent	10,028	12,573
Deferred income taxes	723,000	723,000
Total long-term liabilities	1,345,072	735,573
Total liabilities	3,286,522	5,567,264
Commitments and contingencies
Stockholders' equity (deficit)
Common stock, $0.01 par value, 350,000,000 and 250,000,000 shares authorized; 203,758,698 and 158,280,604 (net of 1,440,000 shares held in treasury stock) shares issued and outstanding at December 31, 2014 and 2013, respectively	2,051,987	1,597,206
Treasury stock	-664,600	-664,600
Discount on common stock	-819,923	-819,923
Additional paid-in capital	72,258,932	67,949,067
Accumulated deficit	-72,785,601	-71,127,447
Total stockholders' equity (deficit)	40,795	-3,065,697
Total liabilities and stockholders' equity (deficit)	$3,327,317	$2,501,567

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current liabilities
Convertible note payable, net of discount	$550,975	$0
Convertible note payable - related party, net of discount	$28,999	$0
Stockholders' equity (deficit)
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	350,000,000	250,000,000
Common stock, shares issued	203,758,698	158,280,604
Common stock, shares outstanding	203,758,698	158,280,604
Treasury stock, shares	1,440,000	1,440,000

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Statements Of Operations
Net Revenues	$1,726,619	$704,189
Operating expenses:
Cost of operations	1,269,081	603,189
Selling, general and administrative expense	4,685,844	1,351,006
Research and development expense	24,090	80,689
Gain on accounts payable write off	-59,899
Gain on deferred revenue write off	-2,998,242
Total operating expenses	2,920,874	2,034,884
Net loss from operations	-1,194,255	-1,330,695
Interest income (expense), net	-191,247	99
Gain on derivative liability	114,848
Loss on conversion of debt from a related party	-387,500
Net loss before income taxes	-1,658,154	-1,330,596
Income tax provision		64,000
Net loss	($1,658,154)	($1,394,596)
Basic and diluted net loss per common share	($0.01)	($0.01)
Basic and diluted net loss per common share	196,487,778	133,559,623

STATEMENTS_OF_STOCKHOLDERS_EQU

STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Common Stock	Treasury Stock	Discount on Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2012	$1,270,503	($664,600)	($819,923)	$67,376,738	($69,732,851)	($2,570,133)
Beginning Balance, Shares at Dec. 31, 2012	127,050,284
Issuance of stock for cash, Shares	32,482,820
Issuance of stock for cash, Amount	324,828			557,329		882,157
Issuances of stock for services, Shares	187,500
Issuances of stock for services, Amount	1,875			15,000		16,875
Expense relating to stock option grants
Net loss					-1,394,596	-1,394,596
Ending Balance, Amount at Dec. 31, 2013	1,597,206	-664,600	-819,923	67,949,067	-71,127,447	-3,065,697
Ending Balance, Shares at Dec. 31, 2013	159,720,604
Issuance of stock for cash, Shares	31,978,094
Issuance of stock for cash, Amount	319,781			516,274		836,055
Issuances of stock for services, Shares	1,000,000
Issuances of stock for services, Amount	10,000			60,000		70,000
Issuance of stock for conversion of debt from related parties, Shares	12,500,000
Issuance of stock for conversion of debt from related parties, Amount	125,000			812,500		937,500
Expense relating to stock option grants				2,921,091		2,921,091
Net loss					-1,658,154	-1,658,154
Ending Balance, Amount at Dec. 31, 2014	$2,051,987	($664,600)	($819,923)	$72,258,932	($72,785,601)	$40,795
Ending Balance, Shares at Dec. 31, 2014	205,198,698

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	($1,658,154)	($1,394,596)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt provision	170,875
Non-cash stock-based compensation	70,000	16,875
Non-cash option expense	2,921,091
Gain on deferred revenue write off	-2,998,242
Gain on derivative liability	-114,848
Gain on accounts payable write off	-59,899
Loss on conversion of debt from a related party	387,500
Amortization of debt discount	112,704
Amortization of deferred financing cost	36,995
Deferred income tax provision		64,000
Change in assets and liabilities:
Accounts receivable	-498,666	101,393
Inventory	-46,463	26,445
Prepaid expenses and other assets	-10,653	-2,327
Accounts payable	215,959	-76,884
Accrued interest payable	39,917
Accrued interest payable - related party	2,101
Accrued compensation	44,561	199,997
Deferred rent	-2,545	-1,493
Net cash used in operating activities	-1,387,767	-1,066,590
Cash flows from financing activities:
Gross proceeds from issuance of convertible note	950,000
Gross proceeds from issuance of convertible note - related party	50,000
Proceeds from issuance of note payable to related parties		450,000
Principal payments on debt due to related party		-100,000
Payments made for deferred financing cost	-135,000
Proceeds from issuance of common stock	836,055	882,157
Net cash provided by financing activities	1,701,055	1,232,157
Net increase in cash and cash equivalents	313,288	165,567
Cash and cash equivalents, beginning	216,913	51,346
Cash and cash equivalents, ending	530,201	216,913
Supplemental disclosure of cash flow information:
Cash paid during the year ended December 31: Interest
Cash paid during the year ended December 31: Income taxes
Non-cash transactions:
Conversion of related party notes to common stock	550,000
Debt discount due to derivative liability	295,773
Debt discount due to warrant issued with convertible note	246,905
Convertible note original issuance cost	150,000
Deferred financing cost due to derivative liability for warrant	$29,550

Nature_of_Business_and_Signifi

Nature of Business and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 1 - Nature of Business and Significant Accounting Policies	Nature of Business
	Fuel Performance Solutions, Inc. (the “Company,” “we,” “us” or “our”) is a company that was incorporated under the laws of the State of Nevada on April 9, 1996. On February 5, 2014, the Company changed its name from International Fuel Technology, Inc. to Fuel Performance Solutions, Inc. We have developed a family of fuel additive product formulations. These unique fuel blends have been created to improve fuel economy, enhance lubricity (reducing engine wear and tear) and lower harmful engine emissions, while decreasing reliance on petroleum-based fuels through the use of more efficient, alternative and renewable fuels. We began transitioning from a development stage technology company to a commercial entity during 2002 and have been increasing our product marketing and sales efforts since. We are now focused on continuing to develop the body of evidence of the efficacy of our products applicable to a wide range of markets and industries within these markets through additional industry specific laboratory testing and customer field-based demonstration testing. In addition, we are continuing to strengthen our distributor and customer contact base. Marketing and sales efforts, in conjunction with the additional industry specific testing, will complete our transition to a commercial enterprise.
	During 2014, our net revenues were split in the following manner: 3% to United States end-user customers and 97% to international distributors and end-user customers. 88% of our net revenues for 2014 were concentrated among 2 customers.
	During 2013, our net revenues were split in the following manner: 9% to United States end-user customers and 91% to international distributors and end-user customers. 92% of our net revenues for 2013 were concentrated among 5 customers.
	At December 31, 2014, 82% of our accounts receivable balance was attributable to 4 customers. At December 31, 2013, 100% of our accounts receivable balance was attributable to 3 customers.
	Customers whose revenues exceeded 10% of our total revenues for 2014 and 2013 are listed below:
	Customer Name	2014			2013
	Nordmann, Rassmann		75	%		74	%
	Unipart Group		13	%		-
	Next Group Brazil		-			12	%
	Net revenues related to shipments into various foreign countries were $1,669,037 and $640,004 during 2014 and 2013, respectively. The following table breaks out net revenues by foreign country:
	Country	2014			2013
	Brazil	$	-		$	88,361
	Czech. Republic		127,980			139,640
	Cyprus		5,665			12,175
	France		29,843			14,495
	Germany		1,103,970			310,649
	Romania		68,336			68,631
	United Kingdom		333,243			6,053
		$	1,669,037		$	640,004
	We currently utilize Brenntag AG (“Brenntag) as our contracted product manufacturer. Brenntag independently purchases required raw materials to manufacture our product. For the years ended December 31, 2014 and 2013, 100% of our product manufacturing has been handled by Brenntag.
	Summaries of our significant accounting policies follow:
	Use of Estimates in the Preparation of Financial Statements
	The preparation of financial statements in conformity with United States generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Reclassifications
	Certain prior year amounts have been reclassified to conform to the current year presentation.
	Concentration of Credit Risk
	Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. We place our cash with high credit quality financial institutions. At times such cash may be in excess of the Federal Deposit Insurance Corporation (“FDIC) limit. With respect to trade receivables, we routinely assess the financial strength of our customers and, as a consequence, believe that our receivable credit risk exposure is limited.
	Related Parties
	A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.
	Revenue Recognition
	We recognize revenue from the sale of our products when the price is fixed and determinable, persuasive evidence of an arrangement exists, the products are shipped, and title and risk of loss has passed to the buyer and collectability of the resulting receivable is reasonably assured. A majority of our revenues is from sales to product distributors. Product distributors do not have the option to return product that is not immediately sold to an end-user. Therefore, our revenue recognition is not conditional on whether a distributor is able to sell product to an ultimate product end-user. Our sales policies for end-users are consistent with product distributor sales policies.
	Beginning in May 2013, as an effort to address our outstanding payable balance with and at the request of our product manufacturer, our non-United States customers began remitting receivable payments directly to our product manufacturer in lieu of remitting payment directly to us. Under this arrangement, we still maintained the risks and benefits related to sending the product to each customer and thus recorded sales revenues (and associated cost of sales) applying the gross reporting treatment for each transaction pursuant to the financial Accounting Standards Board (“FASB“) Accounting Standards Codification (“ASC”) ASC 605-45, “Principal Agent Considerations.” During the first quarter of 2014, we once again began collecting payments directly from our non-United States customers and paying our product manufacturer separately for the corresponding cost of manufactured goods.
	Cash and Cash Equivalents
	Cash and cash equivalents include cash on hand and temporary investments with a maturity of three months or less. We maintain cash in a bank account, which, at times, exceeds federally insured limits. We have experienced no losses relating to these excess amounts of cash in a bank.
	We utilize a cash management program that assesses daily cash requirements. Excess funds are invested in overnight repurchase agreements backed by United States Treasury securities. Repurchase agreements are not deposits, are not insured or guaranteed by the United States government, the FDIC or any other government agency, and involve investment risk including possible loss of principal.
	In addition, during 2014, we established a bank facility that has the functionality to hold cash in various international denominations. As of December 31, 2014, we only had international funds held in euros. The balance of this euro account was marked-to-market as of December 31, 2014.
	Accounts Receivable
	An allowance for doubtful accounts is maintained at a level we believe sufficient to cover potential losses based on historical trends and known current factors impacting our customers. We have determined that an allowance for doubtful accounts was not necessary as of December 31, 2014 and 2013. We did, however, write off $170,875 of accounts receivable from 2013 and 2014 that was expensed in 2014.
	Inventory
	Inventory, which consists solely of finished product, is valued at the lower of cost or market, based on the first-in, first-out (“FIFO”) method, or market, and reflects the purchased cost from vendors. Although we maintain minimal inventory levels in the United States at external storage facilities, the majority of our inventory is manufactured based on customer demand and immediately shipped to customers upon completion. The raw material components required to manufacture our products reside at our product manufacturer’s facilities and are not owned by us.
	Goodwill
	We account for goodwill and intangible assets in accordance with ASC 350 "Intangibles-Goodwill and Other" ("ASC 350"). ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. In addition, ASC 350 requires that goodwill be tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis and between annual tests when circumstances indicate that the recoverability of the carrying amount of goodwill may be in doubt. Application of the goodwill impairment test requires judgment, including the identification of reporting units; assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value. Significant judgments required to estimate the fair value of reporting units include estimating future cash flows, determining appropriate discount rates and other assumptions. Changes in these estimates and assumptions or the occurrence of one or more confirming events in future periods could cause the actual results or outcomes to materially differ from such estimates and could also affect the determination of fair value and/or goodwill impairment at future reporting dates.
	We completed an evaluation of goodwill at December 31, 2014 and 2013 and determined that there was no impairment. We employed a qualitative evaluation for the 2014 and 2013 analyses.
	Income Taxes
	We account for income taxes utilizing ASC 740, “Income Taxes.” ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry-forwards, and of deferred tax liabilities for taxable temporary differences. Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law. The effects of future changes in tax laws or rates are not included in the measurement. We recognize the amount of taxes payable or refundable for the current year and recognize deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in our financial statements or tax returns. We currently have substantial net operating loss (“NOL”) carry-forwards. We have recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
	Research and Development
	Research and development costs are expensed as incurred. Expense for services received from external vendors for 2014 and 2013 was $24,090 and $80,689, respectively.
	Advertising Expenses
	Advertising costs are expensed as incurred and amounted to $173,763 and $56,219 in 2014 and 2013, respectively.
	Basic and Diluted Net Earnings (Loss) Per Common Share
	We account for earnings per share pursuant to ASC 260, “Earnings per Share,” which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the periods, basic and diluted loss per share is the same for the years ended December 31, 2014 and 2013, respectively.
	Derivative Financial Instruments
	We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in our statements of operations. For stock-based derivative financial instruments, we use a Lattice Model option pricing model, in accordance with the ASC 815-15, “Derivatives and Hedging,” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in our balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
	Fair Value of Financial Instruments
	We measure our financial assets and liabilities in accordance with the requirements of ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
	Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
	The following table sets forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value as of December 31, 2014, and December 31, 2013:
	Recurring Fair Value Measures	Level 1			Level 2			Level 3		Total
	31-Dec-14
	Derivative liability	$	-		$	-		$	457,380	$	457,380
	31-Dec-13
Derivative liability	$	-		$	-		$	-	$	-
Employee Stock-Based Compensation
We account for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation” (“ASC 718). ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.
Non-Employee Stock-Based Compensation
We account for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.
Recently Issued Accounting Pronouncements
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

Substantial_Doubt_About_Abilit

Substantial Doubt About Ability to Continue as a Going Concern	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 2 - Substantial Doubt About Ability to Continue as a Going Concern	Our financial statements are presented on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We have incurred significant losses since inception and currently have and previously from time to time have had limited funds with which to operate. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Management is in the process of executing a strategy based upon marketing technologies that offer enhanced engine performance and greater fuel economy along with pollution control benefits.
	During the third quarter of 2014, we raised funds with the issuance of a convertible note. We have been funded since inception primarily by unregistered sales of Company restricted stock, generally to existing shareholders. We believe we still have access to capital from existing shareholders and in addition, management is in the process of executing a plan that we believe will provide us with sufficient funds to allow us to operate through the end of the third quarter of 2015. Specifically, management is currently in discussions with its investment banker and with a strategic investor regarding an equity investment that would allow us to operate for the foreseeable future. However, we can make no assurances that additional capital will be available to us from these sources. Therefore, if we are unable to secure additional capital, we will need to curtail operations.
	The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Stockholders_Equity_Deficit

Stockholders' Equity (Deficit)	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 3 - Stockholders' Equity (Deficit)	On May 22, 2014, we filed a certificate of amendment to our Articles of Incorporation increasing the number of our authorized shares from 250,000,000 to 350,000,000 shares with the Nevada Secretary of State.
	Effective October 27, 1999, we merged with Blencathia Acquisition Corporation (“Blencathia”). Blencathia was a public shell company with immaterial assets and liabilities and 312,000 shares outstanding at the time of the merger, which it redeemed and cancelled upon the merger. In exchange, we issued 312,000 of our common shares to the prior Blencathia owner with the contractual understanding that such shares were to be sold by that owner to achieve gross cash proceeds of $500,000. Any excess proceeds were to be returned to us and any deficiency was to be made up by us issuing additional shares or paying the difference in cash. As we believed that we controlled the ultimate timing of the sale of these 312,000 shares by the prior Blencathia owner, we did not consider these shares as issued or outstanding for purposes of computing earnings per share prior to 2006.
	In 2006, we learned that the prior Blencathia owner had, in fact, sold the 312,000 shares for aggregate proceeds of approximately $150,000, without our consent. Accordingly, in the fourth quarter of 2006, we recorded $500,000 of general expenses (representing the cost of the 1999 merger) and the deemed issuance of approximately $150,000 of common stock. The remaining $350,000 obligation was reflected as a current accrued expense. Beginning in 2006, the 312,000 shares have been reflected as outstanding for earnings per share computations. During 2009 and 2010, we made payments totaling $160,000 to the prior Blencathia owner. We did not make any payments to the prior Blencathia owner during 2011, 2012, 2013 or 2014. The related current accrued expense balance remains at $190,000 at the end of 2014. We are in negotiations with the prior Blencathia owner to resolve this obligation and may ultimately settle the obligation with either cash or equity securities with a lower market value.
	During 2014, we sold an aggregate total of 31,978,094 shares to accredited investors which yielded aggregate proceeds of $836,055.
	During 2013, we sold an aggregate total of 32,482,820 shares to accredited investors which yielded aggregate proceeds of $882,157.
	A detachable warrant to purchase a share of our common stock accompanied certain share purchases in these offerings. The 4,875,000 aggregate warrants issued during 2013 each have an exercise price of $0.10 and were exercisable immediately and up to 5 years.
	On April 12, 2013, our Board of Directors (the “Board”) authorized and approved the extension of expiration date and change of exercise price for 2,000,000 investor warrants granted to a warrant holder for the purchase of the Company’s common stock. The outstanding share purchase warrants originally had a March 23, 2014 expiration date and an exercise price of $0.25. Now the warrant shall expire on April 11, 2018 with an exercise price of $0.25. We analyzed the modification under ASC 718 and ASC 505 and determined no gain or loss is recognized upon the modification due to the warrant having been issued to an investor and investor awards are not subject to either ASC 718 or ASC 505.
	During 2014, we issued 6,666,667 investor warrants pursuant to a convertible note financing and an additional 800,000 warrants for the placement agent that secured the convertible note financing. See Note 6. Convertible Note Payable. During 2014, we also issued 1,418,987 investors warrants pursuant to certain prior investor warrant issuances that are subject to dilutive adjustments for share issuances (full ratchet reset features) tied to future issuances of our equity securities.
	During 2013, we issued a cumulative total of 187,500 common shares to a non-employee consulting entity for services. These shares were valued at the respective settlement dates’ quoted market prices and resulted in an aggregate of $16,875 of recorded non-cash stock-based compensation expense during 2013.
	During the third quarter of 2013, 250,000 warrants associated with a prior financing expired.
	During 2014, 1,000,000 restricted shares were issued to a Director for services which resulted in $70,000 of non-cash stock-based compensation expense. No shares were issued to Directors for Director-related services in 2013.
	As of December 31, 2014 and 2013, we have 28,156,404 and 21,595,750 warrants outstanding, respectively. These warrants were issued as part of equity funding efforts that occurred in 2009, 2011, 2012, 2013 and 2014.
	Year Warrants Issued	No. of			Warrant		Warrant
		Warrants Issued			Exercise Price		Expiration Date
	2009		2,325,000		$	0.25		2014
	2009		2,000,000		$	0.15		2018
	2011		2,570,750		$	0.25		2016
	2011		250,000		$	0.25		2013
	2012		9,825,000		$	0.1		2017
	2013		4,875,000		$	0.1		2018
	2014		7,466,667		$	0.12		2019
	2014		1,418,987		$	0.15		2018
	No warrants were exercised during 2014 or 2013.
	Further information relating to warrants is as follows:
					Weighted		Weighted
		Number			Average		Average
		of			Exercise		Remaining
		Shares			Price		Life
	Outstanding at December 31, 2012		16,970,750		$	0.16		3.55
	Granted		4,875,000		$	0.1		4.26
	Expired		(250,000	)	$	0.25		-
	Outstanding at December 31, 2013		21,595,750		$	0.15		3.35
	Granted		8,885,654		$	0.12		4.42
	Expired		(2,325,000	)	$	0.25		-
	Outstanding at December 31, 2014		28,156,404		$	0.12		3.26
	The intrinsic value (difference between the warrant exercise price and our stock share price) attributable to warrants issued was $0 at both December 31, 2014 and 2013.

Stock_Options

Stock Options	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 4 - Stock Options	Long Term Incentive Plan
	On October 23, 2001, the Board adopted our Long Term Incentive Plan (“LTIP”). The Board is responsible for the administration of this LTIP, and is the approval authority for all option grant awards under this plan. Subject to the express provisions of the LTIP, the Board shall have full authority and sole and absolute discretion to interpret and amend this LTIP, to prescribe, amend and rescind rules and regulations relating to it, and to make all other determinations which it believes to be necessary or advisable in administering this LTIP.
	On October 22, 2006, our Board adopted the Amended and Restated LTIP. This plan expires on October 21, 2016.
	The maximum number of shares of common stock as to which awards may be granted under this plan, subject to subsequent amendments, is 18,200,000 shares (updated to reflect the 4% dividend issued during the first quarter of 2009). The common stock issued upon exercise of options or on grant of stock awards may be shares previously authorized but not yet issued or shares which have been issued and reacquired by the Company as treasury stock. The Board may increase the maximum number of shares of common stock as to which awards may be granted at such time as it deems advisable.
	The following tables summarize information about stock options issued to employees and Directors during the 2 years ended December 31, 2014:
		Shares			Exercise price		Weighted-average exercise price			Aggregate
					per share					intrinsic value
	Outstanding at December 31, 2012		11,497,120		$0.09-0.96		$	0.43
	Expired		(2,008,000	)	$0.21-0.96		$	0.53
	Outstanding at December 31, 2013		9,489,120		$0.09-0.50		$	0.41
	Granted		30,276,000		$0.05-0.15		$	0.1
	Cancelled		(7,070,400	)	$0.09-0.50		$	0.39
	Expired		(2,220,000	)	$0.18-0.48		$	0.46
	Outstanding at December 31, 2014		30,474,720		$0.05-0.50		$	0.1		$	404,337
	Options exercisable at December 31, 2014		27,641,386		$0.05-0.50		$	0.1
	Options exercisable at December 31, 2013		9,489,120		$0.09-0.50		$	0.41
	The following table summarizes information about employee stock options outstanding at December 31, 2014:
		Options outstanding										Options exercisable
	Exercise price range	Number outstanding at December 31,				Weighted-average remaining contractual			Weighted-average			Number exercisable at December 31,		Weighted-average
		2014				life (years)			exercise price			2014		exercise price
	$0.05 - $0.25		30,348,880				4		$	0.1			27,515,546	$	0.1
	$0.26 - $0.50		125,840				1		$	0.44			125,840	$	0.44
			30,474,720				4		$	0.1			27,641,386	$	0.1
	The following table summarizes information about employee stock options outstanding at December 31, 2013:
		Options outstanding										Options exercisable
	Exercise price range	Number outstanding at December 31,				Weighted-average remaining contractual			Weighted-average			Number exercisable at December 31,		Weighted-average
		2013				life (years)			exercise price			2013		exercise price
	$0.09 - $0.25		2,435,760				1		$	0.2			2,435,760	$	0.2
	$0.26 - $0.50		7,053,360				1		$	0.48			7,053,360	$	0.48
			9,489,120				1		$	0.41			9,489,120	$	0.41
	The following table summarizes information about stock options issued to non-employees during the 2 years ended December 31, 2014:
		Shares			Exercise price		Weighted-average exercise price			Aggregate
					per share					intrinsic value
	Outstanding at December 31, 2012		4,781,599		$0.25-0.96		$	0.49
	Expired		(644,000	)	$0.25-0.96		$	0.57
	Outstanding at December 31, 2013		4,137,599		$0.25-0.50		$	0.46
	Granted		5,730,000		$0.05-0.25		$	0.18
	Cancelled		(1,907,000	)	$0.10-0.48		$	0.37
	Expired		(2,535,599	)	$0.25-0.50			-
	Outstanding at December 31, 2014		5,425,000		$0.05-0.25		$	0.19		$	8,700
	Options exercisable at December 31, 2014		5,425,000		$0.05-0.25		$	0.19
	Options exercisable at December 31, 2013		4,132,399		$0.25-0.50		$	0.46
	Stock option expense recorded in 2014 and 2013 is as follows:
		Year Ended December 31, 2014				Year Ended December 31, 2013
	Awards to employees/Directors	$	2,492,541			$	-
	Awards to non-employees		428,550				-
	Total stock option expense	$	2,921,091			$	-
	Employee and Director Awards
	During 2014, we issued 22,651,200 options to employees and 7,624,800 options to Directors for Director-related services. These option grants were issued in conjunction with the cancellation of 7,070,400 options that had previously been issued to employees and Directors. We calculated the fair value of the to-be cancelled options on the cancellation date and netted the fair value against the fair value of the new grant options. The cancellation of these options resulted in $36,446 of stock option expense reversal. In addition, 2,220,000 fully vested options previously granted to employees and Directors (in their capacity as Directors) expired during 2014.
	During 2013, we did not grant any options to employees or to Directors in their capacity as Directors. In addition, 2,008,000 fully vested options previously granted to employees and Directors (in their capacity as Directors) expired during 2013.
	The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the years indicated:
		Year Ended December 31, 2014					Year Ended
							31-Dec-13
	Weighted-average fair value of options granted	$	0.09				NA
	Weighted-average assumptions:
	Risk-free interest rate		0.67	%			NA
	Dividend yield		-				NA
	Expected volatility		1.92				NA
	Expected option life (years)		5				NA
	As of December 31, 2014, there was $149,671 of total unrecognized compensation cost related to outstanding options granted to employees and Directors. As of December 31, 2013, there was $0 of total unrecognized compensation cost related to outstanding options granted to employees and Directors as all options previously granted to employees and Directors were fully vested as of December 31, 2013.
	Non-employee awards
	During 2014, we granted 5,730,000 stock options to non-employees. We also cancelled 1,907,000 stock options previously granted to non-employees, resulting in $3, 653 of stock option expense reversal. 2,535,599 fully vested options previously granted to non-employees expired in 2014.
	We did not grant any stock options to non-employees during 2013. However, 644,000 fully vested options previously granted to non-employees expired in 2013.
	We did not receive proceeds for stock options exercised during 2014 or 2013, as no options were exercised.
Services performed by non-employees who were granted options include product/distribution consulting, technology consulting, investor relations and legal services. The weighted-average fair value for such options that have had a fair value calculation applied ($0.08 for 2014 and NA for 2013) was estimated at the date of grant using a Black-Scholes option pricing model. The following weighted-average assumptions were used for the 2014 grants: risk-free interest rate of 0.43%, volatility factor of 2.13, and a weighted-average expected life of the option of approximately 4.40 years.
The weighted-average remaining contractual term (in years) of the non-employee options outstanding at December 31, 2014 and 2013 is 2.57 and 0.73, respectively.
The aggregate intrinsic value (defined as the excess of the market price of our common stock as of the end of the period over the exercise price of the related stock options) for all stock options (employee, Director and non-employee) outstanding and exercisable as of December 31, 2014 and 2013 was $413,037 and $0 for the respective periods.

Equity_Commitment_and_Related_

Equity Commitment and Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 5 - Equity Commitment and Related Party Transactions	On August 22, 2014, the Company borrowed $50,000 from Jonathan Burst, our Board chairman and Chief Executive Officer. This loan was pursuant to the convertible note payable transaction discussed in Note 6. Convertible Note Payable below.
	Effective December 11, 2007, we received an investment commitment from Rex Carr, a Director of the Company and a holder of over 5% of our common stock. Pursuant to the terms of the commitment, Mr. Carr has agreed to invest up to an aggregate of $1,000,000 in the Company, at such time or times as we may request, in the form of a purchase or purchases of our restricted common stock. We may elect to draw from the commitment at one time or from time to time; provided, however, that the aggregate of such draws may not exceed $1,000,000. If and when we elect to utilize available commitment funds, we will issue to Mr. Carr that number of our shares of restricted common stock equal to the value of the investment then provided to us. The number of shares to be issued will be calculated based on the closing price of our common stock as quoted on OTC Market Group’s OTCQB marketplace on the date of the sale. There is no stipulation regarding the duration of this commitment. As of December 31, 2014, $500,000 remains available under this equity commitment.
	As of December 31, 2013, the Company owed $500,000 to Mr. Carr. The terms of the loans associated with this cumulative loan balance did not require the payment of interest and did not require repayment of the principal by a certain date. On February 6, 2014, we issued 10,000,000 restricted shares of Company common stock in exchange for the cancellation of this note payable from a related party in the aggregate (face amount) of $500,000. The fair value of the shares issued based on the February 6, 2014 closing price of our stock ($0.075) was $750,000. This conversion of notes payable from a related party to restricted shares of our common stock was treated separately from the equity commitment in place with Mr. Carr.
	On February 4, 2013, David B. Norris, a Director of the Company, loaned us $50,000. The terms of this loan did not require the payment of interest and did not require repayment of the principal by a certain date. This loan was converted to 2,500,000 shares of the Company’s common stock on February 6, 2014. The fair value of the shares issued based on the February 6, 2014 closing price of our stock ($0.075) was $187,500.
	In conjunction with the conversion of Mr. Carr’s and Mr. Norris’ notes payable from a related party to equity, we recorded a $387,500 loss on the conversion of related party notes to our income statement during the twelve months ended December 31, 2014.
	In 2013, we received $450,000 of advances from related parties and made payments to related parties of $100,000. The advances were received from the following: Mr. Carr ($350,000), Mr. Norris ($50,000) and Mr. Burst ($50,000). The payments made (in aggregate) to related parties during 2013 consisted of the following: Mr. Carr ($50,000) and Mr. Burst ($50,000).

Convertible_Note_Payable

Convertible Note Payable	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 6 - Convertible Note Payable	On August 22, 2014 (the “Closing Date”), we closed a financing transaction by entering into a Securities Purchase Agreement dated August 22, 2014 (the “Securities Purchase Agreement”) with certain funds and investors signatory to such Securities Purchase Agreement (the “Purchasers”) for an aggregate subscription amount of $1,000,000 (the “Purchase Price”) of which $50,000 is from a related party. Pursuant to the Securities Purchase Agreement, we issued the following to the Purchasers: (i) 10% Convertible Promissory Notes with an aggregate principal amount of $1,150,000 (the “Notes”), and (ii) warrants to purchase an aggregate of 6,666,667 shares of the Company’s common stock, par value $0.01 per share, for an exercise price of $0.12 per share for a period of five (5) years from the effective date of the registration statement (the “Warrants”).
	We recorded $150,000 of original issuance cost related to this transaction, which we have recorded as debt discount.
	The terms of the Notes and the Warrants are as follows:
	10% Convertible Promissory Notes
	The total principal amount of the Notes is issued with a 115% premium to the subscription amount. The Notes accrue interest at a rate equal to 10% per annum and have a maturity date of February 22, 2016. The Notes are convertible any time after the issuance date of the Notes. The Purchasers have the right to convert the Notes into shares of the Company’s common stock at a conversion price equal to $0.10 per share, subject to standard adjustments for stock dividends, stock splits, subsequent equity sales, subsequent rights offerings and pro rata distributions. While the Notes are outstanding, in the event of a subsequent equity sale at a price lower than the conversion price of $0.10 per share, the conversion price of the Notes shall be reduced to the lower conversion price. The Notes can be redeemed under certain conditions and the Company can force the conversion of the Notes in the event certain equity conditions are met.
	In the event of default, the Purchasers have the right to require the Company to repay in cash all or a portion of the Notes at a price equal to 125% of the aggregate principal amount of the Notes plus all accrued but unpaid interest.
	Warrants
	The Warrants are exercisable in whole or in part, at an initial exercise price per share of $0.12, subject to adjustment. The exercise price and number of shares of the Company’s common stock issuable under the Warrants (the “Warrant Shares”) are subject to adjustments for stock dividends, splits, combinations, subsequent rights offerings, pro rata distributions and any issuance of securities below the exercise price of the Warrants. While the Warrants are outstanding, in the event of a subsequent equity sale including a warrant exercise price lower than the exercise price of $0.12 per share, the exercise price of the Warrants shall be reduced to the lower exercise price. Any adjustment to the exercise price shall similarly cause the number of Warrant Shares to be adjusted so that the total value of the Warrants may increase, provided, that in no event shall the number of Warrant Shares exceed 200% of the original number of Warrant Shares originally issued.
	In addition to the Warrants described above, the Company also issued 800,000 warrants to a placement agent assisting with the convertible note transaction. The terms of the placement agent warrants are the same as of the terms of the Warrants explained above.
	Registration Rights Agreement
	In connection with the sale of Notes and Warrants pursuant to the Securities Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Purchasers, pursuant to which the Company agreed to register all of the shares of common stock underlying the Notes and the shares of common stock underlying the Warrants (together, the “Registrable Securities”) on a Form S-1 registration statement (the “Registration Statement”) to be filed with the SEC within thirty (30) calendar days following the Closing Date (the “Filing Deadline”) and to use its best efforts to cause the Registration Statement to be declared effective under the Securities Act within 100 calendar days following the Closing Date (the “Effectiveness Deadline”). The Registration Statement became effective November 26, 2014.
	Deferred Financing Cost
	In connection with the convertible note transaction explained above, the Company paid $55,000 for legal fees and $80,000 for placement agent fees. In addition, $29,550 was also recorded to deferred financing costs related to the fair value valuation of the placement agent warrants. $36,995 of deferred financing costs was amortized during 2014. The deferred financing cost balance is $127,555 as of December 31, 2014.
	Derivative
	Because the above convertible debt and warrants have full reset adjustments tied to future issuances of equity securities by the Company, it is subject to derivative liability treatment under ASC 815-40-15, “Determining Whether an Instrument (or Embedded Feature) is Indexed to an Entity’s Own Stock” (“ASC 815-40-15”). ASC 815-40-15 requires as of the date the convertible debt and warrants are issued, the derivative liability to be measured at the fair value and re-evaluated at the end of each reporting period. See Note 7. Derivative Liability.
	On issuance date the fair value of the derivative liability for both the convertible debt and warrants was $295,773 and $246,905, respectively. Therefore a total of $692,678 (including $150,000 original issuance costs) of debt discount was recorded. During the twelve months ended December 31, 2014, $112,704 was recorded as amortization of debt discount. As of December 31, 2014, the convertible debt has a balance of $541,525, net of $550,975 of debt discount and accrued interest of $39,917.
	As of December 31, 2014, the related party convertible note has a balance of $28,501, net of $28,999 of debt discount and accrued interest of $2,101.

Derivative_Liability

Derivative Liability	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 7 - Derivative Liability	During 2009, we granted a warrant to purchase 2,000,000 shares of the Company’s common stock to an accredited investor in conjunction with equity raise efforts. On April 12, 2013, our Board authorized and approved the extension of the expiration date and a change of exercise price for this warrant. The outstanding share purchase warrant originally had a March 23, 2014 expiration date and an exercise price of $0.25. The new modified terms extended the warrant expiration date to April 11, 2018 and reduced the exercise price to $0.25. The exercise price is also subject to dilutive adjustments for share issuances (full ratchet reset features). As of December 31, 2014, the exercise price has been reduced to $0.15 and an additional 1,418,987 warrants are to be issued to the investor due to the reset features.
	On August 22, 2014, we issued 6,666,667 warrants to investors and 800,000 warrants to a placement agent. The exercise price of these warrants is also subject to dilutive adjustments for share issuance (full ratchet reset features). See Note 6. Convertible Note Payable.
	Because these convertible debt and warrants have full reset adjustments tied to future issuances of equity securities by the Company, it is subject to derivative liability treatment under ASC 815-40-15, which requires as of the date the convertible debt and warrants are issued, the derivative liability to be measured at fair value and re-evaluated at the end of each reporting period.
	Key assumptions used to determine the fair value of the convertible note follows:
	Stock price volatility (one-year measurement):
	August 22, 2014 measurement		219	%
	December 31, 2014 measurement		192	%
	Probability of default triggering 21% interest rate, increasing 1% per month to a maximum of 10% with a 125% penalty		0	%
	Probability of the Company redeeming the convertible note (with 130% penalty): projected initially at 0% of the time, increasing 1% monthly to a maximum of 5% (from alternative financing being available for a redemption event to occur)
	Conversion behavior - holder automatically converts the convertible note at a maximum of 2 times the conversion price
	Key assumptions used to determine the fair value of the warrants follows:
	Stock price volatility (one-year measurement):
	August 22, 2014 measurement		219	%
	31-Dec-14		192	%
	Exercise behavior – warrant exercise at target prices 2 times the higher of the projected reset price or stock price
	As of December 31, 2013, we determined the fair value of the warrant’s derivative liability to be nominal.
	As of December 31, 2014, the fair value of the total convertible debt and warrant’s derivative liability is $457,380 and we recognized a gain on derivative liability of $114,848 for the twelve months ended December 31, 2014.
	The following table summarizes the derivative liability included in the balance sheet:
	Balance at December 31, 2013	$	-
	Debt discount due to convertible note		295,773
	Debt discount due to warrant issued with debt		246,905
	Deferred financing cost due to derivative liability for placement agent warrant		29,550
	Gain on change of fair value		(114,848	)
	Balance at December 31, 2014	$	457,380

Deferred_Revenue

Deferred Revenue	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 8 - Deferred Revenue	On February 26, 2009, we received the first purchase order pursuant to a Memorandum of Understanding (“MOU”) with Libya Oil Holdings Limited, Tamoil, Libya Africa Investment Portfolio and Vision Oil Services Ltd (“VOS”). Pursuant to the MOU, VOS paid for the purchase of 600 metric tons of DiesoLiFTTM 10 at a price of 6,000 Euros (approximately $7,600) per metric ton from us. We received cash proceeds of approximately $3 million from VOS in February 2009. No such revenues had been recorded to date relating to this order because there has been no requested delivery of the product. We have had no communication with VOS in over five years and believe they have ceased all activities on our behalf.
	Based upon a written legal opinion received during the first quarter of 2014, it was determined that effective February 2014, we were no longer obligated to present the nearly $3 million deferred revenue liability on our balance sheet as the statute of limitations period for our performance obligation has passed. In conjunction with this determination, we recorded a gain on deferred revenue liability write off of approximately $3 million during the twelve months ended December 31, 2014.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 9 - Income Taxes	We use the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.
	We have historically incurred losses from operations and therefore had no tax liability. The net deferred asset generated by the NOL carry-forward has been fully reserved. The cumulative NOL carry-forward is approximately $47.9 million and $46 million for 2014 and 2013, respectively and will begin expiring in 2017.
	Deferred tax assets consist of the tax effect of NOL carry-forwards. We have provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding their realizability. However, because goodwill is not depreciated and has an indefinite life for book purposes, the deferred tax liability related to the book to tax basis difference is not offset against the deferred tax assets when establishing our valuation allowance. Accordingly, we recorded $64,000 of non-cash deferred income tax expense, which increased the deferred tax liability, during the twelve months ended December 31, 2013. Deferred tax assets consist of the following:
		Year ended December 31,
		2014			2013
	Deferred tax asset	$	19,161,984		$	18,406,251
	Valuation allowance		(19,161,984	)		(18,406,251	)
	Deferred tax liability	$	723,000		$	723,000

Lease_Commitments

Lease Commitments	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 10 - Lease Commitments	We entered into an operating lease for office space on January 1, 2002 that, as extended, now expires on April 30, 2017. Rent expense was $43,937 and $43,457 during the fiscal years ended December 31, 2014 and 2013, respectively. We entered into new a new 5-year office equipment lease in July 2014.
	Future minimum lease payments as of December 31, 2014 are displayed below:
	Year ending December 31,
	2015	$	48,820
	2016	$	49,874
	2017	$	17,918
	2018	$	1,764
	2019	$	882
	Total minimum lease payments	$	119,258
	Future minimum lease payments as of December 31, 2013 are displayed below:
	Year ending December 31,
	2014	$	47,206
	2015	$	47,056
	2016	$	48,110
	2017	$	16,154
	2018	$	-
	Total minimum lease payments	$	158,526

Accounts_Payable

Accounts Payable	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 11 - Accounts Payable	As of December 31, 2014, we recognized a $59,899 gain on write off of accounts payable. The invoice and contracts for the total of $59,899 were dated at least five years before December 31, 2014. Based on a written legal opinion received during the third quarter of 2014, it was determined that effective September 30, 2014, we were no longer obligated to present the $59,899 of accounts payable on our balance sheet as the statute of limitation period for our payment obligation has passed. In conjunction with this determination, we recorded a gain on accounts payable write off of $59,899 during the twelve months ended December 31, 2014.

Legal_Proceedings

Legal Proceedings	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
Note 12 - Legal Proceedings	We are periodically subject to various lawsuits and claims with respect to matters arising out of the normal course of business. While the impact on future financial results is not subject to reasonable estimation because considerable uncertainty exists, management believes, after consulting with counsel, that it is more likely than not that the ultimate liabilities resulting from such lawsuits and claims will not materially affect our financial position, results of operations or liquidity.
	On July 31, 2006, we received notice from the American Arbitration Association (“AAA”) of a Demand for Arbitration dated July 27, 2006 received by the AAA naming the Company as Respondent and TPG Capital Partners (“TPG”), the prior Blencathia owner, as the Claimant. The arbitration had been requested by TPG to resolve an alleged aggregate proceeds shortfall from the sale of our securities issued in the Blencathia merger. TPG has claimed they sold some or all of the 312,000 shares and the sales have not generated at least $500,000 of proceeds, as guaranteed in the merger documents.
	In an effort to resolve this matter prior to submission to binding arbitration, both TPG and the Company participated in a non-binding mediation conference on January 30, 2007, which did not resolve the matter. Informal discussions are ongoing. It is not expected that the ultimate settlement of this matter, considering we have recorded a liability for the shortfall amount, will have an additional adverse material effect on the Company. Since 2009, the Company has made payments to TPG totaling $160,000 to reduce the recorded liability. The remaining recorded liability balance is $190,000 at December 31, 2014 and 2013, respectively.

Significant_Accounting_Policie

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Significant Accounting Policies Policies
Use of Estimates in the Preparation of Financial Statements	The preparation of financial statements in conformity with United States generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassifications	Certain prior year amounts have been reclassified to conform to the current year presentation.
Concentration of Credit Risk	Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. We place our cash with high credit quality financial institutions. At times such cash may be in excess of the Federal Deposit Insurance Corporation (“FDIC) limit. With respect to trade receivables, we routinely assess the financial strength of our customers and, as a consequence, believe that our receivable credit risk exposure is limited.
Related Parties	A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.
Revenue Recognition	We recognize revenue from the sale of our products when the price is fixed and determinable, persuasive evidence of an arrangement exists, the products are shipped, and title and risk of loss has passed to the buyer and collectability of the resulting receivable is reasonably assured. A majority of our revenues is from sales to product distributors. Product distributors do not have the option to return product that is not immediately sold to an end-user. Therefore, our revenue recognition is not conditional on whether a distributor is able to sell product to an ultimate product end-user. Our sales policies for end-users are consistent with product distributor sales policies.
	Beginning in May 2013, as an effort to address our outstanding payable balance with and at the request of our product manufacturer, our non-United States customers began remitting receivable payments directly to our product manufacturer in lieu of remitting payment directly to us. Under this arrangement, we still maintained the risks and benefits related to sending the product to each customer and thus recorded sales revenues (and associated cost of sales) applying the gross reporting treatment for each transaction pursuant to the financial Accounting Standards Board (“FASB“) Accounting Standards Codification (“ASC”) ASC 605-45, “Principal Agent Considerations.” During the first quarter of 2014, we once again began collecting payments directly from our non-United States customers and paying our product manufacturer separately for the corresponding cost of manufactured goods.
Cash and Cash Equivalents	Cash and cash equivalents include cash on hand and temporary investments with a maturity of three months or less. We maintain cash in a bank account, which, at times, exceeds federally insured limits. We have experienced no losses relating to these excess amounts of cash in a bank.
	We utilize a cash management program that assesses daily cash requirements. Excess funds are invested in overnight repurchase agreements backed by United States Treasury securities. Repurchase agreements are not deposits, are not insured or guaranteed by the United States government, the FDIC or any other government agency, and involve investment risk including possible loss of principal.
	In addition, during 2014, we established a bank facility that has the functionality to hold cash in various international denominations. As of December 31, 2014, we only had international funds held in euros. The balance of this euro account was marked-to-market as of December 31, 2014.
Accounts Receivable	An allowance for doubtful accounts is maintained at a level we believe sufficient to cover potential losses based on historical trends and known current factors impacting our customers. We have determined that an allowance for doubtful accounts was not necessary as of December 31, 2014 and 2013. We did, however, write off $170,875 of accounts receivable from 2013 and 2014 that was expensed in 2014.
Inventory	Inventory, which consists solely of finished product, is valued at the lower of cost or market, based on the first-in, first-out (“FIFO”) method, or market, and reflects the purchased cost from vendors. Although we maintain minimal inventory levels in the United States at external storage facilities, the majority of our inventory is manufactured based on customer demand and immediately shipped to customers upon completion. The raw material components required to manufacture our products reside at our product manufacturer’s facilities and are not owned by us.
Goodwill	We account for goodwill and intangible assets in accordance with ASC 350 "Intangibles-Goodwill and Other" ("ASC 350"). ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. In addition, ASC 350 requires that goodwill be tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis and between annual tests when circumstances indicate that the recoverability of the carrying amount of goodwill may be in doubt. Application of the goodwill impairment test requires judgment, including the identification of reporting units; assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value. Significant judgments required to estimate the fair value of reporting units include estimating future cash flows, determining appropriate discount rates and other assumptions. Changes in these estimates and assumptions or the occurrence of one or more confirming events in future periods could cause the actual results or outcomes to materially differ from such estimates and could also affect the determination of fair value and/or goodwill impairment at future reporting dates.
	We completed an evaluation of goodwill at December 31, 2014 and 2013 and determined that there was no impairment. We employed a qualitative evaluation for the 2014 and 2013 analyses.
Income Taxes	We account for income taxes utilizing ASC 740, “Income Taxes.” ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry-forwards, and of deferred tax liabilities for taxable temporary differences. Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law. The effects of future changes in tax laws or rates are not included in the measurement. We recognize the amount of taxes payable or refundable for the current year and recognize deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in our financial statements or tax returns. We currently have substantial net operating loss (“NOL”) carry-forwards. We have recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
Research and Development	Research and development costs are expensed as incurred. Expense for services received from external vendors for 2014 and 2013 was $24,090 and $80,689, respectively.
Advertising Expenses	Advertising costs are expensed as incurred and amounted to $173,763 and $56,219 in 2014 and 2013, respectively.
Basic and Diluted Net Earnings (Loss) Per Common Share	We account for earnings per share pursuant to ASC 260, “Earnings per Share,” which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the periods, basic and diluted loss per share is the same for the years ended December 31, 2014 and 2013, respectively.
Derivative Financial Instruments	We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in our statements of operations. For stock-based derivative financial instruments, we use a Lattice Model option pricing model, in accordance with the ASC 815-15, “Derivatives and Hedging,” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in our balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	We measure our financial assets and liabilities in accordance with the requirements of ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
	Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
	Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
	The following table sets forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value as of December 31, 2014, and December 31, 2013:
	Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
	31-Dec-14
	Derivative liability	$	-	$	-	$	457,380	$	457,380
	31-Dec-13
	Derivative liability	$	-	$	-	$	-	$	-
Employee Stock-Based Compensation	We account for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation” (“ASC 718). ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.
Non-Employee Stock-Based Compensation	We account for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.
Recently Issued Accounting Pronouncements	Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

Nature_of_Business_and_Signifi1

Nature of Business and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Nature Of Business And Significant Accounting Policies Tables
Schedules of Concentration of Revenue	Customers whose revenues exceeded 10% of our total revenues for 2014 and 2013 are listed below:
	Customer Name	2014			2013
	Nordmann, Rassmann		75	%		74	%
	Unipart Group		13	%		-
	Next Group Brazil		-			12	%
Net revenues by foreign country	The following table breaks out net revenues by foreign country:
	Country	2014			2013
	Brazil	$	-		$	88,361
	Czech. Republic		127,980			139,640
	Cyprus		5,665			12,175
	France		29,843			14,495
	Germany		1,103,970			310,649
	Romania		68,336			68,631
	United Kingdom		333,243			6,053
		$	1,669,037		$	640,004
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table sets forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value as of December 31, 2014, and December 31, 2013:
	Recurring Fair Value Measures	Level 1			Level 2			Level 3		Total
	31-Dec-14
	Derivative liability	$	-		$	-		$	457,380	$	457,380
	31-Dec-13
	Derivative liability	$	-		$	-		$	-	$	-

Stockholders_Equity_Deficit_Ta

Stockholders' Equity (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2014
Stockholders Equity Deficit Tables
Schedule of Warrants Issued	Year Warrants Issued	No. of			Warrant		Warrant
		Warrants Issued			Exercise Price		Expiration Date
	2009		2,325,000		$	0.25		2014
	2009		2,000,000		$	0.15		2018
	2011		2,570,750		$	0.25		2016
	2011		250,000		$	0.25		2013
	2012		9,825,000		$	0.1		2017
	2013		4,875,000		$	0.1		2018
	2014		7,466,667		$	0.12		2019
	2014		1,418,987		$	0.15		2018
Schedule of Information related to Warrants	Further information relating to warrants is as follows:
					Weighted		Weighted
		Number			Average		Average
		of			Exercise		Remaining
		Shares			Price		Life
	Outstanding at December 31, 2012		16,970,750		$	0.16		3.55
	Granted		4,875,000		$	0.1		4.26
	Expired		(250,000	)	$	0.25		-
	Outstanding at December 31, 2013		21,595,750		$	0.15		3.35
	Granted		8,885,654		$	0.12		4.42
	Expired		(2,325,000	)	$	0.25		-
	Outstanding at December 31, 2014		28,156,404		$	0.12		3.26

Stock_Options_Tables

Stock Options (Tables)	12 Months Ended
	Dec. 31, 2014
Stock Options Tables
Schedule of Stock Option Issued to Employees and Directors	The following tables summarize information about stock options issued to employees and Directors during the 2 years ended December 31, 2014:
		Shares			Exercise price		Weighted-average exercise price			Aggregate
					per share					intrinsic value
	Outstanding at December 31, 2012		11,497,120		$0.09-0.96		$	0.43
	Expired		(2,008,000	)	$0.21-0.96		$	0.53
	Outstanding at December 31, 2013		9,489,120		$0.09-0.50		$	0.41
	Granted		30,276,000		$0.05-0.15		$	0.1
	Cancelled		(7,070,400	)	$0.09-0.50		$	0.39
	Expired		(2,220,000	)	$0.18-0.48		$	0.46
	Outstanding at December 31, 2014		30,474,720		$0.05-0.50		$	0.1		$	404,337
	Options exercisable at December 31, 2014		27,641,386		$0.05-0.50		$	0.1
	Options exercisable at December 31, 2013		9,489,120		$0.09-0.50		$	0.41
Schedule of Employee Stock Option Outstanding	The following table summarizes information about employee stock options outstanding at December 31, 2014:
		Options outstanding										Options exercisable
	Exercise price range	Number outstanding at December 31,				Weighted-average remaining contractual			Weighted-average			Number exercisable at December 31,		Weighted-average
		2014				life (years)			exercise price			2014		exercise price
	$0.05 - $0.25		30,348,880				4		$	0.1			27,515,546	$	0.1
	$0.26 - $0.50		125,840				1		$	0.44			125,840	$	0.44
			30,474,720				4		$	0.1			27,641,386	$	0.1
	The following table summarizes information about employee stock options outstanding at December 31, 2013:
		Options outstanding										Options exercisable
	Exercise price range	Number outstanding at December 31,				Weighted-average remaining contractual			Weighted-average			Number exercisable at December 31,		Weighted-average
		2013				life (years)			exercise price			2013		exercise price
	$0.09 - $0.25		2,435,760				1		$	0.2			2,435,760	$	0.2
	$0.26 - $0.50		7,053,360				1		$	0.48			7,053,360	$	0.48
			9,489,120				1		$	0.41			9,489,120	$	0.41
Schedule of Stock Option Issued to non employees	The following table summarizes information about stock options issued to non-employees during the 2 years ended December 31, 2014:
		Shares			Exercise price		Weighted-average exercise price			Aggregate
					per share					intrinsic value
	Outstanding at December 31, 2012		4,781,599		$0.25-0.96		$	0.49
	Expired		(644,000	)	$0.25-0.96		$	0.57
	Outstanding at December 31, 2013		4,137,599		$0.25-0.50		$	0.46
	Granted		5,730,000		$0.05-0.25		$	0.18
	Cancelled		(1,907,000	)	$0.10-0.48		$	0.37
	Expired		(2,535,599	)	$0.25-0.50			-
	Outstanding at December 31, 2014		5,425,000		$0.05-0.25		$	0.19		$	8,700
	Options exercisable at December 31, 2014		5,425,000		$0.05-0.25		$	0.19
	Options exercisable at December 31, 2013		4,132,399		$0.25-0.50		$	0.46
Schedule of Stock Option Recorded	Stock option expense recorded in 2014 and 2013 is as follows:
		Year Ended December 31, 2014				Year Ended December 31, 2013
	Awards to employees/Directors	$	2,492,541			$	-
	Awards to non-employees		428,550				-
	Total stock option expense	$	2,921,091			$	-
Schedule of primary assumptions used to value employee and Director non-cash stock-based compensation	The following table provides the primary assumptions used to value employee and Director non-cash stock-based compensation for the years indicated:
		Year Ended December 31, 2014					Year Ended
							31-Dec-13
	Weighted-average fair value of options granted	$	0.09				NA
	Weighted-average assumptions:
	Risk-free interest rate		0.67	%			NA
	Dividend yield		-				NA
	Expected volatility		1.92				NA
	Expected option life (years)		5				NA

Derivative_Liability_Tables

Derivative Liability (Tables)	12 Months Ended
	Dec. 31, 2014
Derivative Liability Tables
Fair value of convertible note	Key assumptions used to determine the fair value of the convertible note follows:
	Stock price volatility (one-year measurement):
	August 22, 2014 measurement		219	%
	December 31, 2014 measurement		192	%
	Probability of default triggering 21% interest rate, increasing 1% per month to a maximum of 10% with a 125% penalty		0	%
	Probability of the Company redeeming the convertible note (with 130% penalty): projected initially at 0% of the time, increasing 1% monthly to a maximum of 5% (from alternative financing being available for a redemption event to occur)
	Conversion behavior - holder automatically converts the convertible note at a maximum of 2 times the conversion price
	Key assumptions used to determine the fair value of the warrants follows:
	Stock price volatility (one-year measurement):
	August 22, 2014 measurement		219	%
	31-Dec-14		192	%
Summary of derivative liability	The following table summarizes the derivative liability included in the balance sheet:
	Balance at December 31, 2013	$	-
	Debt discount due to convertible note		295,773
	Debt discount due to warrant issued with debt		246,905
	Deferred financing cost due to derivative liability for placement agent warrant		29,550
	Gain on change of fair value		(114,848	)
	Balance at December 31, 2014	$	457,380

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Taxes Tables
Deferred tax liability	Deferred tax assets consist of the following:
		Year ended December 31,
		2014			2013
	Deferred tax asset	$	19,161,984		$	18,406,251
	Valuation allowance		(19,161,984	)		(18,406,251	)
	Deferred tax liability	$	723,000		$	723,000

Lease_Commitments_Tables

Lease Commitments (Tables)	12 Months Ended
	Dec. 31, 2014
Lease Commitments Tables
Schedule of Minimum Future Lease Payment	Future minimum lease payments as of December 31, 2014 are displayed below:
	Year ending December 31,
	2015	$	48,820
	2016	$	49,874
	2017	$	17,918
	2018	$	1,764
	2019	$	882
	Total minimum lease payments	$	119,258
	Future minimum lease payments as of December 31, 2013 are displayed below:
	Year ending December 31,
	2014	$	47,206
	2015	$	47,056
	2016	$	48,110
	2017	$	16,154
	2018	$	-
	Total minimum lease payments	$	158,526

Nature_of_Business_and_Signifi2

Nature of Business and Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Net revenue in percentage	10.00%	10.00%
Nordmann, Rassmann [Member]
Net revenue in percentage	75.00%	74.00%
Unipart Group [Member]
Net revenue in percentage	13.00%
Next Group Brazil [Member]
Net revenue in percentage		12.00%

Nature_of_Business_and_Signifi3

Nature of Business and Significant Accounting Policies (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Employee and Director awards [Member]
Net sales revenues	$1,669,037	$640,004
Brazil [Member]
Net sales revenues		88,361
Czech Republic [Member]
Net sales revenues	127,980	139,640
Cyprus [Member]
Net sales revenues	5,665	12,175
France [Member]
Net sales revenues	29,843	14,495
Germany [Member]
Net sales revenues	1,103,970	310,649
Romania [Member]
Net sales revenues	68,336	68,631
United Kingdom [Member]
Net sales revenues	$333,243	$6,053

Nature_of_Business_and_Signifi4

Nature of Business and Significant Accounting Policies (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Derivative liability	$457,380
Level 1 [Member]
Derivative liability
Level 2 [Member]
Derivative liability
Level 3 [Member]
Derivative liability	$457,380

Nature_of_Business_and_Signifi5

Nature of Business and Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
	Integer	Integer
Nature Of Business And Significant Accounting Policies Details Narrative
Accounts receivable in percent	82.00%	100.00%
Number of customers	4	3
Sales revenues exceeded in percentage	10.00%	10.00%
Net sales revenues	$1,669,037	$640,004
Production handled by Brenntag	100.00%	100.00%
Accounts receivable write off	170,875	170,875
Advertising costs	173,763	56,219
Expense for services received	$24,090	$80,689

Stockholders_Equity_Deficit_De

Stockholders Equity (Deficit) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
2009
No of warrants issued	2,325,000
Warrant Exercise Price	$0.25
Warrant Expiration Date	2014
2009
No of warrants issued	2,000,000
Warrant Exercise Price	$0.15
Warrant Expiration Date	2018
2011
No of warrants issued	2,570,750
Warrant Exercise Price	$0.25
Warrant Expiration Date	2016
2011
No of warrants issued	250,000
Warrant Exercise Price	$0.25
Warrant Expiration Date	2013
2012
No of warrants issued	9,825,000
Warrant Exercise Price	$0.10
Warrant Expiration Date	2017
2013
No of warrants issued	4,875,000
Warrant Exercise Price	$0.10
Warrant Expiration Date	2018
2014
No of warrants issued	7,466,667
Warrant Exercise Price	$0.12
Warrant Expiration Date	2019
2014
No of warrants issued	1,418,987
Warrant Exercise Price	$0.15
Warrant Expiration Date	2018

Stockholders_Equity_Deficit_De1

Stockholders Equity (Deficit) (Details 1) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Warrant [Member]
Number of Shares
Outstanding, Beginning	21,595,750	16,970,750
Granted	8,885,654	4,875,000
Expired	-2,325,000	-250,000
Outstanding, Ending	28,156,404	21,595,750
Weighted Average Exercise Price
Outstanding, Beginning	$0.15	$0.16
Granted	$0.12	$0.10
Expired	$0.25	$0.25
Outstanding, Ending	$0.12	$0.15
Weighted average remaining life Outstanding at beginning of year	3 years 4 months 6 days	3 years 6 months 18 days
Granted	4 years 5 months 1 day	4 years 3 months 4 days
Weighted average remaining life Outstanding at end of year	3 years 3 months 4 days	3 years 4 months 6 days

Stockholders_Equity_Deficit_De2

Stockholders Equity (Deficit) (Details Narrative)	Dec. 31, 2014	Dec. 31, 2013
Stockholders Equity Deficit Details Narrative
Warrants outstanding	28,156,404	21,595,750
Warrants issued	0	0

Stock_Options_Details

Stock Options (Details) (Employees and Directors [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Number of Shares
Outstanding, Beginning	9,489,120	11,497,120
Granted	30,276,000
Cancelled	-7,070,400
Expired	-2,220,000	-2,008,000
Outstanding, Ending	30,474,720	9,489,120
Exercisable	27,641,386	9,489,120
Weighted Average Exercise Price
Outstanding, Beginning	$0.41	$0.43
Granted	$0.10
Cancelled	$0.39
Expired	$0.46	$0.53
Outstanding, Ending	$0.10	$0.41
Exercisable	$0.10	$0.41
Aggregate intrinsic value	$404,337
Minimum [Member]
Exercise Price Per Share
Exercise price, Beginning	$0.09	$0.09
Granted	$0.05
Cancelled	$0.09
Expired	$0.18	$0.21
Exercise price, Ending	$0.05	$0.09
Exercisable	$0.05	$0.09
Maximum [Member]
Exercise Price Per Share
Exercise price, Beginning	$0.50	$0.96
Granted	$0.15
Cancelled	$0.50
Expired	$0.48	$0.96
Exercise price, Ending	$0.50	$0.50
Exercisable	$0.50	$0.50

Stock_Options_Details_1

Stock Options (Details 1) (Employees, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Number outstanding	30,474,720	9,489,120
Weighted average remaining contractual life	4 years	1 year
Weighted average exercise price	$0.10	$0.41
Number exercisable	27,641,386	9,489,120
Weighted average exercise price exercisable	$0.10	$0.41
0.05 - 0.25
Number outstanding	30,348,880	2,435,760
Weighted average remaining contractual life	4 years	1 year
Weighted average exercise price	$0.10	$0.20
Number exercisable	27,515,546	2,435,760
Weighted average exercise price exercisable	$0.10	$0.20
0.05 - 0.25 | Minimum [Member]
Exercise Prices	$0.05	$0.09
0.05 - 0.25 | Maximum [Member]
Exercise Prices	$0.25	$0.25
0.26 - 0.50
Number outstanding	125,840	7,053,360
Weighted average remaining contractual life	1 year	1 year
Weighted average exercise price	$0.44	$0.48
Number exercisable	125,840	7,053,360
Weighted average exercise price exercisable	$0.44	$0.48
0.26 - 0.50 | Minimum [Member]
Exercise Prices	$0.26	$0.26
0.26 - 0.50 | Maximum [Member]
Exercise Prices	$0.50	$0.50

Stock_Options_Details_2

Stock Options (Details 2) (Non-employees, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Number of Shares
Outstanding, Beginning	4,137,599	4,781,599
Granted	5,730,000
Cancelled	-1,907,000
Expired	-2,535,599	-644,000
Outstanding, Ending	5,425,000	4,137,599
Exercisable	5,425,000	4,132,399
Weighted Average Exercise Price
Outstanding, Beginning	$0.46	$0.49
Granted	$0.18
Cancelled	$0.37
Expired		$0.57
Outstanding, Ending	$0.19	$0.46
Exercisable	$0.19	$0.46
Aggregate intrinsic value	$8,700
Minimum [Member]
Exercise Price Per Share
Exercise price, Beginning	$0.25	$0.25
Granted	$0.05
Cancelled	$0.10
Expired	$0.25	$0.25
Exercise price, Ending	$0.05	$0.25
Exercisable	$0.05	$0.25
Maximum [Member]
Exercise Price Per Share
Exercise price, Beginning	$0.50	$0.96
Granted	$0.25
Cancelled	$0.48
Expired	$0.50	$0.96
Exercise price, Ending	$0.25	$0.50
Exercisable	$0.25	$0.50

Stock_Options_Details_3

Stock Options (Details 3) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Options Details 3
Awards to employees/Directors	$2,492,541
Awards to non-employees	428,550
Total stock option expense	$2,921,091

Stock_Options_Details_4

Stock Options (Details 4) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Options Details 3
Weighted-average fair value of options granted	$0.09
Weighted-average assumptions:
Risk-free interest rate	0.67%
Dividend yield
Expected volatility	192.00%
Expected option life (years)	5 years

Stock_Options_Details_Narrativ

Stock Options (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
The weighted-average remaining contractual term (in years)	2 years 6 months 26 days	8 months 23 days
Aggregate intrinsic value	$413,037	$0
Employee and Director awards [Member]
Employees option granted	$149,671	$0

Equity_Commitment_and_Related_1

Equity Commitment and Related Party Transactions (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Equity Commitment And Related Party Transactions Details Narrative
Amount available for equity commitments	$500,000
Amount Payable for related party		500,000
Loss on conversion of debt from a related party	$387,500

Convertible_Note_Payable_Detai

Convertible Note Payable (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Convertible Note Payable Details Narrative
Deferred financing cost	$127,555
Amortization of debt discount	112,704
Convertible note payable	541,525
Convertible note payable, Net of debt discount	550,975
Accrued interest payable	39,917
Convertible note payable - related party, net of discount of $28,999 and $0, respectively	28,501
Convertible note payable, Net of discount	28,999
Accrued interest - related party	$2,101

Derivative_Liability_Details

Derivative Liability (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock price volatility	192.00%
December 31, 2014 measurement [Member]
Stock price volatility	192.00%
Probability of default triggering [Member]
Stock price volatility	0.00%
Convertible Note [Member] | August 22, 2014 measurement [Member]
Stock price volatility	219.00%
Warrant [Member] | August 22, 2014 measurement [Member]
Stock price volatility	219.00%
Warrant [Member] | December 31, 2014 [Member]
Stock price volatility	192.00%

Derivative_Liability_Details_1

Derivative Liability (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014
Derivative Liability Details 1
Derivative liability, Beginning Balance
Debt discount due to convertible note	295,773
Debt discount due to warrant issued with debt	246,905
Deferred financing cost due to derivative liability for placement agent warrant	29,550
Gain on change of fair value	-114,848
Derivative liability, Ending Balance	$457,380

Derivative_Liability_Details_N

Derivative Liability (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Derivative Liability Details Narrative
Exercise price reduce	$0.15
Warrants are issued to the investor	1,418,987
Derivative liability	$457,380
Gain on derivative liability	$114,848

Deferred_Revenue_Details_Narra

Deferred Revenue (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014
Deferred Revenue Details Narrative
Gain on deferred revenue liability	$3,000,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Taxes Details
Deferred tax asset	$19,161,984	$18,406,251
Less: Valuation allowance	-19,161,984	-18,406,251
Deferred tax liability	$723,000	$723,000

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Taxes Details
Income tax provision		$64,000
Net Operative Loss carry forward	$47,900,000	$46,000,000
Expiration starting year	2017

Lease_Commitments_Details

Lease Commitments (Details) (USD $)	Dec. 31, 2014
Lease Commitments Details
2015	$48,820
2016	49,874
2017	17,918
2018	1,764
2019	882
Total minimum lease payments	$119,258

Lease_Commitments_Details_1

Lease Commitments (Details 1) (USD $)	Dec. 31, 2013
Lease Commitments Details 1
2014	$47,206
2015	47,056
2016	48,110
2017	16,154
2018
Total minimum lease payments	$158,526

Lease_Commitments_Details_Narr

Lease Commitments (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Lease Commitments Details
Rent expense	$43,937	$43,457

Accounts_Payable_Details_Narra

Accounts Payable (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Accounts Payable Details Narrative
Gain on accounts payable write off	($59,899)

Legal_Proceedings_Details_Narr

Legal Proceedings (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Legal Proceedings Details Narrative
Other accrued expenses	$190,000	$190,000